Gurabo Risperdal

risperidone · Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gurabo Risperdal, covering 2018-02-28 to 2018-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy Participants [Phase 1]

See pricing